Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 673 to 675 of 675 entries
Sorted by: Best Match Show Resources per page
A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.

Vaccine

Lamm DL, Morales A.
PMID: 34417051
Vaccine. 2021 Dec 08;39(50):7308-7318. doi: 10.1016/j.vaccine.2021.08.026. Epub 2021 Aug 18.

BCG remains the most important vaccine for tuberculosis 100 years after its first use, and over the past 4 decades it has become the most widely accepted, effective drug used in the treatment of aggressive localized bladder cancer. This...

Cite
Lamm DL, Morales A. A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment. Vaccine. 2021;39(50):7308-7318doi: 10.1016/j.vaccine.2021.08.026.
Lamm, D. L., & Morales, A. (2021). A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment. Vaccine, 39(50), 7308-7318. https://doi.org/10.1016/j.vaccine.2021.08.026
Lamm, Donald L, and Morales, Alvaro. "A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment." Vaccine vol. 39,50 (2021): 7308-7318. doi: https://doi.org/10.1016/j.vaccine.2021.08.026
Lamm DL, Morales A. A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment. Vaccine. 2021 Dec 08;39(50):7308-7318. doi: 10.1016/j.vaccine.2021.08.026. Epub 2021 Aug 18. PMID: 34417051.
Copy Download .nbib Format: NLM
Pull-out strength evaluation of cement augmented iliac screws in osteoporotic spino-pelvic fixation.

Orthopaedics & traumatology, surgery & research : OTSR

Oberkircher L, Masaeli A, Hack J, Figiel J, Bliemel C, Ruchholtz S, Krüger A.
PMID: 33895387
Orthop Traumatol Surg Res. 2021 Nov;107(7):102945. doi: 10.1016/j.otsr.2021.102945. Epub 2021 Apr 22.

INTRODUCTION: Spino-pelvic fixation has been widely accepted for surgical treatment of sacral tumor, scoliosis surgery and pelvic fractures. Cement augmentation of screws is an option to improve implant stability in osteoporotic bone quality. Aim of the present study is...

Cite
Oberkircher L, Masaeli A, Hack J, et al. Pull-out strength evaluation of cement augmented iliac screws in osteoporotic spino-pelvic fixation. Orthop Traumatol Surg Res. 2021;107(7):102945doi: 10.1016/j.otsr.2021.102945.
Oberkircher, L., Masaeli, A., Hack, J., Figiel, J., Bliemel, C., Ruchholtz, S., & Krüger, A. (2021). Pull-out strength evaluation of cement augmented iliac screws in osteoporotic spino-pelvic fixation. Orthopaedics & traumatology, surgery & research : OTSR, 107(7), 102945. https://doi.org/10.1016/j.otsr.2021.102945
Oberkircher, Ludwig, et al. "Pull-out strength evaluation of cement augmented iliac screws in osteoporotic spino-pelvic fixation." Orthopaedics & traumatology, surgery & research : OTSR vol. 107,7 (2021): 102945. doi: https://doi.org/10.1016/j.otsr.2021.102945
Oberkircher L, Masaeli A, Hack J, Figiel J, Bliemel C, Ruchholtz S, Krüger A. Pull-out strength evaluation of cement augmented iliac screws in osteoporotic spino-pelvic fixation. Orthop Traumatol Surg Res. 2021 Nov;107(7):102945. doi: 10.1016/j.otsr.2021.102945. Epub 2021 Apr 22. PMID: 33895387.
Copy Download .nbib Format: NLM
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis.

EBioMedicine

Martínez-Bosch N, Cristóbal H, Iglesias M, Gironella M, Barranco L, Visa L, Calafato D, Jiménez-Parrado S, Earl J, Carrato A, Manero-Rupérez N, Moreno M, Morales A, Guerra C, Navarro P, García de Frutos P.
PMID: 34973624
EBioMedicine. 2021 Dec 29;75:103797. doi: 10.1016/j.ebiom.2021.103797. Epub 2021 Dec 29.

BACKGROUND: Early diagnosis is crucial for patients with pancreatic ductal adenocarcinoma (PDAC). The AXL receptor tyrosine kinase is proteolytically processed releasing a soluble form (sAXL) into the blood stream. Here we explore the use of sAXL as a biomarker...

Cite
Martínez-Bosch N, Cristóbal H, Iglesias M, et al. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine. 2021;75:103797doi: 10.1016/j.ebiom.2021.103797.
Martínez-Bosch, N., Cristóbal, H., Iglesias, M., Gironella, M., Barranco, L., Visa, L., Calafato, D., Jiménez-Parrado, S., Earl, J., Carrato, A., Manero-Rupérez, N., Moreno, M., Morales, A., Guerra, C., Navarro, P., & García de Frutos, P. (2021). Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine, 75103797. https://doi.org/10.1016/j.ebiom.2021.103797
Martínez-Bosch, Neus, et al. "Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis." EBioMedicine vol. 75 (2021): 103797. doi: https://doi.org/10.1016/j.ebiom.2021.103797
Martínez-Bosch N, Cristóbal H, Iglesias M, Gironella M, Barranco L, Visa L, Calafato D, Jiménez-Parrado S, Earl J, Carrato A, Manero-Rupérez N, Moreno M, Morales A, Guerra C, Navarro P, García de Frutos P. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine. 2021 Dec 29;75:103797. doi: 10.1016/j.ebiom.2021.103797. Epub 2021 Dec 29. PMID: 34973624; PMCID: PMC8724936.
Copy Download .nbib Format: NLM
Showing 673 to 675 of 675 entries